Menopause Hormone Replacement Therapy reduced Heart Failure and Heart Attack Risk

Stethoscope - BSN

(Best Syndication News) - A study found that women who took hormone replacement therapy (HRT) for ten years had a reduced risk for heart failure and heart attack compared to women who did not take the therapy. The positive effects of taking HRT therapy appears to be a reduction in cardiovascular disease, but on the negative side, there is an increased risk for developing breast cancer. The new study suggests that the cardiovascular benefits are present without having an increased risk for cancer, deep vein thrombosis, or stroke.

The randomized trial-study was conducted in Denmark over a ten-year period. The researchers had followed-up after an additional six years to assess if HRT reduced heart disease risk if therapy started soon after menopause.

Reduced Risk of Stroke from eating Tomatoes

Credit: National Cancer Institute Renee Comet (Photographer) PD

(Best Syndication News) - Researchers found that people who had the highest levels of lycopene in their blood had a 55 percent reduced risk for stroke compared to those who had the lowest levels. Tomatoes contain an abundant amount of lycopene, which is an antioxidant. The study results were published in the October 9, 2012 print edition of Neurology.

The research involved 1,031 men from Finland between 46 and 65 years of age. The men were followed for an average of 12 years. At the start of the study, their blood levels of lycopene were measured. Over the duration of the study, 67 men suffered a stroke.

Kraft Jalapeno String Cheese Recall announced for Packaging Concern

Kraft Jalapeno String Cheese recall - FDA

(Best Syndication News) - The US Food and Drug Administration announced a voluntary recall by Kraft for their Jalapeno flavored String Cheese products because the plastic film in the packaging could remain stuck to the food. The concern is that the plastic might put a person at risk of choking. Only the Kraft String Cheese with the Jalapeno flavor and the “Best if Used By” date of “23 NOV 2012” are involved in this recall.

The recall was announced after a consumer complained of the problem. Around 2,700 cases are involved in the recall. The recalled cheese was shipped across the United States, but not into Canada.

The Jalapeno string cheese comes packaged in a 12 ounce bag that has 12 individually 1-ounce-sized portions. The UPC code is 2100002977 and only the packages that have the “Best if Used by” date of November 23, 2012 are being recalled. The expiration date is on the back of the main 12-ounce bag in the lower-right corner. All other Kraft String Cheese is safe to eat.

Elderly Women’s Brains function better with Daily Low Dose Aspirin Regimen

Aspirin - BSN

(Best Syndication News) - Brain function declined less in elderly women who took a daily low-dose aspirin. These women, who were also at a high risk for heart disease, had less mental decline compared to women who did not take the daily aspirin. The study results were published in the online journal BMJ Open.

The researchers suggest that inflammation associated with heart disease may also influence the way the brain ages.

In the study, 681 women between 70 and 92 were investigated. Out of these women, 601 were at a high risk for having heart disease or a stroke. Their risk was at a 10 percent rate or higher, based on the Framingham scale.

Vitamin D supplements did not ease Colds in Duration or Frequency

(Best Syndication News) - A study from New Zealand found that vitamin D3 supplements did not reduce the frequency or severity of colds. The randomized controlled trial tested monthly dosage of 100,000 IUs of vitamin D3. The results were published in the October 3, 2012 issue of JAMA.

The researchers wanted to see if supplementation would reduce the frequency and severity of respiratory tract infections. Previous studies have suggested that a vitamin D insufficiency would make a person more vulnerable for catching a cold.

David R. Murdoch, M.D., of the University of Otago, Christchurch, New Zealand, and colleagues recruited 322 healthy adults who participated in the study between February 2010 and November 2011. Half of the participants were randomly assigned to be given 200,000 IU of vitamin D3 orally at the start of the trial, then another 200,000 IU dose one month later. Then, they were given 100,000 IU dose each month for the remainder of the study. The remaining half was given a placebo pill to take on the same schedule and method. The study lasted for 18 months.

Syndicate content


Post to Facebook

Important: The material on Best Syndication is for informational purposes only and is not meant to be advice. Authors may have or will receive monetary compensation from the company's product/s mentioned. You should always seek professional advice before making any legal, financial or medical decisions and this website cannot substitute or replace any trained professional consultation.
Use of this site means that you agree to our TERMS OF SERVICE

Advertise On This Site
Copyright © 2006-2015 By Best Syndication All Rights Reserved